[43,54–57] In contrast, IDH2 and DNMT3A are key epigenetic regulators, and pre-leukaemic driver mutations in these genes occur early in AML development and are associated with the pre-leukaemic HSC compartment. Here, IDH2 is linked to acute myeloid leukemia.